Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC)Marie Y. Detrait, Mauricette Michallet, Stéphane Vigouroux et al.|Blood|2012Cited by 0